Telesis Bio Inc. (TBIO) Cost of Revenue USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Telesis Bio Inc. quarterly/annual Cost of Revenue history and growth rate from 2020 to 2023.
  • Telesis Bio Inc. Cost of Revenue for the quarter ending March 31, 2024 was $1.99 M, a 28.9% decline year-over-year.
  • Telesis Bio Inc. Cost of Revenue for the twelve months ending March 31, 2024 was $9.75 M, a 17.3% decline year-over-year.
  • Telesis Bio Inc. annual Cost of Revenue for 2023 was $10.6 M, a 10.8% decline from 2022.
  • Telesis Bio Inc. annual Cost of Revenue for 2022 was $11.8 M, a 75.6% increase from 2021.
  • Telesis Bio Inc. annual Cost of Revenue for 2021 was $6.74 M, a 129% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.6 M -$1.28 M -10.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $11.8 M +$5.1 M +75.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $6.74 M +$3.79 M +129% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $2.95 M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.